Abstract
Recombinant Listeria monocytogenes expressing a type-common herpes simplex virus (HSV) gB-peptide was shown previously to protect against footpad inoculation with HSV-1. We tested this construct for protection against vaginal challenge with HSV-2. Primed mice demonstrated strong recall responses, had modest reductions in HSV-2 DNA in vaginal mucosa, but were not protected from disease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1165-1169 |
| Number of pages | 5 |
| Journal | Archives of Virology |
| Volume | 153 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2008 |
Funding
This work was supported in part by the following grants to SSW: NIH-K08HD51584, a Wyeth Infectious Disease Society of America award, Puget Sound Partners for Global Health, and a March of Dimes Basil O’Conner starter research award. WJM was supported by NIH grant T32 AI007411 and by a Child Health Research Career Development Award through the Department of Pediatrics, Feinberg School of Medicine, and Children’s Memorial Research Center at Northwestern University. DMK is supported in part by NIH AI50132. We thank Dr. Gregg Milligan (University of Texas Medical Branch, Galveston, TX) for HSV-2 strain 186, which was grown and titered by Chris McClurkan.
ASJC Scopus subject areas
- Virology